Skip to main navigation Skip to search Skip to main content

Findings from Hospital Pablo Tobon Uribe in the Area of Type 2 Diabetes Reported (Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis)

    Press/Media: Press / Media

    PeriodJun 18 2026

    Media coverage

    1

    Media coverage

    • TitleFindings from Hospital Pablo Tobon Uribe in the Area of Type 2 Diabetes Reported (Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis)
      Media name/outletClinical Trials Daily
      Date6/18/26
      PersonsAdriana Alzate Echeverri